It is likely that IL-38 functions as an anti-inflammatory cytokine in IBD, based on the present evidence, which shows that the IL-38/IL-36R pathway may be a new direction for therapeutic intervention in IBD, further study is needed to confirm that conclusion. The gene discussed is IL1F10; the disease is inflammatory bowel disease.